DURACLON dosage forms and strengths: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Clonidine}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click here'''''. ==Dosage Forms and Strengths== {{Cite web ...") |
|||
| Line 7: | Line 7: | ||
==Dosage Forms and Strengths== | ==Dosage Forms and Strengths== | ||
{{Cite web | last = | first = | title = DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638 | publisher = | date = | accessdate = | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638#i4i_clinical_pharmacology_id_a61d4026-7aae-4211-9bb5-332675db4e46 | publisher = | date = | accessdate = 6 February 2014 }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 16:45, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information, click here.
Dosage Forms and Strengths
References
- ↑ "DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]". Retrieved 6 February 2014.